Morgan Stanley raised the firm’s price target on Microsoft (MSFT) to $530 from $482 and keeps an Overweight rating on the shares after the firm updated its capex-implied AI revenue analysis and its OpenAI model detailing the contribution to Azure. While investors continue to debate the “Return on Investment” of rising capital expenditures, the firm sees the yields on Microsoft’s investments in Generative AI “becoming increasingly apparent,” says the analyst, who expresses increased confidence in upside to Azure forecasts. Microsoft’s “prime position for the upcoming GenAI innovation cycle matched with solid execution is driving an acceleration in the Azure business,” the analyst argues.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MSFT:
- Microsoft’s Strategic AI Investments and Financial Discipline Drive Buy Rating with Increased Price Target
- Microsoft, OpenAI contract talks hinge on AGI, WSJ reports
- Wedbush Lifts Microsoft Price Target to $600, Hails AI as ‘Shining Moment’
- AI and Cloud Push Microsoft Stock (MSFT) Towards Long-Term Supremacy
- Microsoft opens AI co-innovation lab on University of Wisconsin-Milwaukee campus
